1. Report Introduction
2. Chronic Obstructive Pulmonary Disease (COPD) Epidemiology Overview at a Glance
3. Market Share Distribution of Chronic Obstructive Pulmonary Disease (COPD)
4. Disease Background and Overview: Chronic Obstructive Pulmonary Disease (COPD)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Chronic Obstructive Pulmonary Disease (COPD) Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Chronic Obstructive Pulmonary Disease (COPD)
7.3. Sub-Type Specific cases of Chronic Obstructive Pulmonary Disease (COPD)*
7.4. Sex- Specific Cases of Chronic Obstructive Pulmonary Disease (COPD)*
7.5. Diagnosed Cases of Chronic Obstructive Pulmonary Disease (COPD)
7.6. Treated Cases of Chronic Obstructive Pulmonary Disease (COPD)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.1.3. Sub-Type Specific cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.1.4. Sex- Specific Cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.1.5. Diagnosed Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.1.6. Treated Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.2.3. Sub-Type Specific cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.2.4. Sex- Specific Cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.2.5. Diagnosed Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.2.6. Treated Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.3.3. Sub-Type Specific cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.3.4. Sex- Specific Cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.3.5. Diagnosed Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.3.6. Treated Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.4.3. Sub-Type Specific cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.4.4. Sex- Specific Cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.4.5. Diagnosed Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.4.6. Treated Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.5.3. Sub-Type Specific cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.5.4. Sex- Specific Cases of Chronic Obstructive Pulmonary Disease (COPD)*
8.5.5. Diagnosed Cases of Chronic Obstructive Pulmonary Disease (COPD)
8.5.6. Treated Cases of Chronic Obstructive Pulmonary Disease (COPD)
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Chronic Obstructive Pulmonary Disease (COPD)
9.3. Sub-Type Specific cases of Chronic Obstructive Pulmonary Disease (COPD)*
9.4. Sex- Specific Cases of Chronic Obstructive Pulmonary Disease (COPD)*
9.5. Diagnosed Cases of Chronic Obstructive Pulmonary Disease (COPD)
9.6. Treated Cases of Chronic Obstructive Pulmonary Disease (COPD)
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.